2016
DOI: 10.1016/j.abb.2016.06.010
|View full text |Cite
|
Sign up to set email alerts
|

Cystathionine: A novel oncometabolite in human breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
39
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(41 citation statements)
references
References 25 publications
2
39
0
Order By: Relevance
“…Scientific reports describe the CBS and CTH roles in breast cancer models [16,37]. The CBS expression measured by different methods was described in breast cancer tissues by Sen et al [17], but they reported no CTH presence in the collected tissue samples. On the contrary, You et al [37] described the CTH expression in MCF-7 cells and provided the results supporting its significant role in the breast cancer development.…”
Section: Discussionmentioning
confidence: 99%
“…Scientific reports describe the CBS and CTH roles in breast cancer models [16,37]. The CBS expression measured by different methods was described in breast cancer tissues by Sen et al [17], but they reported no CTH presence in the collected tissue samples. On the contrary, You et al [37] described the CTH expression in MCF-7 cells and provided the results supporting its significant role in the breast cancer development.…”
Section: Discussionmentioning
confidence: 99%
“…In general, the average cystathionine level in higher grade gliomas (II/III, III/IV, IV) was higher relative to low‐grade gliomas (II), with no genetic information provided . Abnormal accumulation of cystathionine in breast cancer was also reported, and cystathionine was suggested to be a novel oncometabolite possibly contributing to drug resistance in cancer cells.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, metabolomics, which analyzes all observable metabolites in biological samples, has emerged as a new promising tool for identification of therapeutic targets and diagnostic and prognostic markers in cancer research [ 5 ]. Recent studies have described essential metabolomic pathways in breast cancer and characterized oncometabolites that drove tumor growth and progression [ 6 8 ]. Furthermore, in order to obtain information on cellular function of metabolites, analyses of metabolites coupled with genetic or lipidomic profiling have been performed [ 9 , 10 ].…”
Section: Introductionmentioning
confidence: 99%